Evaluation of an HPV16-L1 antibody rapid test for oropharyngeal cancer diagnosis: diagnostic accuracy and challenges in real-world settings
Open Access
- 11 December 2025
- journal article
- Published by Elsevier in EBioMedicine
- Vol. 123, 106057
Abstract
No abstract availableKeywords
Funding Information
- German Cancer Research Center
- National Research Council Canada
- Ministry of Health
- University of Cologne
- Bundesministerium für Forschung, Technologie und Raumfahrt
This publication has 35 references indexed in Scilit:
- Detection of antibody subclasses IgA, IgM and IgG against HPV L1 in HPV-positive oropharyngeal squamous cell carcinoma patients: a pilot studyEuropean Archives of Oto-Rhino-Laryngology, 2024
- Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccinationVaccine, 2022
- HPV and head and neck cancers: Towards early diagnosis and preventionTumour Virus Research, 2022
- Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young womenTumour Virus Research, 2022
- Oral and laryngeal HPV infection: Incidence, prevalence and risk factors, with special regard to concurrent infection in head, neck and genitalsVaccine, 2021
- Global incidence trends in head and neck cancer for HPV-related and -unrelated subsites: A systematic review of population-based studiesOral Oncology, 2021
- Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix® or Gardasil® vaccineVaccine, 2019
- Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16‐driven oropharyngeal squamous cell carcinomaInternational Journal of Cancer, 2017
- Prevention of cervical cancer: journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccineCurrent Opinion in Chemical Biology, 2016
- Antibodies against high‐risk human papillomavirus proteins as markers for invasive cervical cancerInternational Journal of Cancer, 2014